Global Cell-free Protein Expression Market Report 2022: Increasing R&D in Proteomics and Genomics Drives Growth – ResearchAndMarkets.com

Global Cell-free Protein Expression Market Report 2022: Increasing R&D in Proteomics and Genomics Drives Growth - ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cell-free Protein Expression Market Share, Size, Trends, Industry Analysis Report, By Application, By Product, By Method, By End-Use, By Region, Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global cell-free protein expression market size is expected to reach USD 470.45 million by 2030 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing R&D in proteomics and genomics, higher prevalence of cancerous and infectious diseases, shorter expression time, and structural modification are the factors raising the industry. Also, increasing demands for novel biologic products for treating several chronic diseases, including cancer, anemia, and multiple sclerosis, drive the industry’s growth.

Rapid and high-throughput expression of mutant protein for functional analysis, labeling of protein with stable isotopes for structural analysis, analysis of components required for protein folding, production of functional virons or toxic polypeptides, experiments to characterize protein-protein interaction and protein-nucleic acid interaction, and expression to mammalian protein with proper glycosylation and native post-translational modifications are some significant applications driving the growth of the industry.

Cell-free Protein Expression Market Report Highlights

Biologists at Toronto University removed the enzyme required for transcription and translation from E. coli to develop a system that identifies the parts of the SARS-CoV-2 genome and activates a molecular shift to generate a reporter protein that eradicates the purified RNA from the sample replacing RT-PCR for additional rapid diagnostic testing.

The enzyme engineering segment is the largest revenue share in 2021, as it benefits bio-manufacturing synthetic biology and medicines.

The high throughput production is expected to grow faster over the forecast due to the utilization of CFPS for high throughput enzyme screening which has been proved to be a proper technique for determining enzyme variants and novel biocatalysts.

The transcription and translation method accounts for the most significant market revenue as it makes it easy and consumes investigators’ time by combining the processes of in vitro transcription and translation in a single tube format.

North America is expected for the highest market share. In this region, the United States holds the largest market share due to the country’s increasing burden of cancer cases, which is anticipated to stimulate the demand for the industry.

The global market is highly competitive owing to the existence of large industry players with a global presence Biotechrabbit GmbH, CellFree Sciences Co., Ltd., Cube Biotech GmbH, GeneCopoeia, Inc., Jena Bioscience GmbH, Merck KGaA, New England BioLabs, Promega Corporation, Takara Bio Company, Thermo Fisher Scientific, Inc.

The publisher has segmented the cell-free protein expression market report based on products, applications, methods, end-uses, and regions:

Cell-free Protein Expression, Product Outlook (Revenue – USD Million, 2018 – 2030)

Expression systems

coli cell-free protein expression system

Wheat germ cell-free protein expression system

Rabbit reticulocytes cell-free protein expression system

Insert cell cell-free protein expression system

Human cell-free protein expression system

Others

Reagents

Cell-free Protein Expression, Applications Outlook (Revenue – USD Million, 2018 – 2030)

Enzyme Engineering

High Throughput production

Protein labelling

Protein-protein interaction

Protein purification

Cell-free Protein Expression, Method Outlook (Revenue – USD Million, 2018 – 2030)

Transcription and translation system

Translation system

Cell-Free Protein Expression, End Use Outlook (Revenue – USD Million, 2018 – 2030)

Pharmaceutical and Biotechnology companies

Academic and research institutes

Others

Cell-Free Protein Expression, Regional Outlook (Revenue – USD Million, 2018 – 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Cell-free Protein Expression Market Insights

5. Global Cell-free Protein Expression Market, by Application

6. Global Cell-free Protein Expression Market, by Products

7. Global Cell-free Protein Expression Market, by Methods

8. Global Cell-free Protein Expression Market, by End-Usese

9. Global Cell-free Protein Expression Market, by Geography

10. Competitive Landscape

11. Company Profiles

Companies Mentioned

Biotechrabbit GmbH

CellFree Sciences Co. Ltd.

Cube Biotech GmbH

GeneCopoeia Inc.

Jena Bioscience GmbH

Merck KGaA

New England BioLabs

Promega Corporation

Takara Bio Company

Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/v0r4uj

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.